ABSTRACT
Disorders of lipid and lipoprotein metabolism in individuals with insulin resistance or diabetes mellitus type 2 increase cardiovascular risks. The most common characteristics of lipid disorders in insulin-resistant individuals are elevations of triglycerides and low levels of high-density lipoprotein (HDL)-cholesterol. Accordingly, the American Diabetes Association recommends searching for underlying glucose intolerance in individuals with dyslipidemia (HDL cholesterol <0.90mmol/L, [<35mg/dL] and/or a triglyceride level ‡2.82mmol/L [‡250mg/dL]) with an oral glucose tolerance test (1).
